Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate.

Elliott GR, Blasey C, Rekshan W, Rush AJ, Palmer DM, Clarke S, Kohn M, Kaplan C, Gordon E.

J Atten Disord. 2014 Aug 13. pii: 1087054714543924. [Epub ahead of print]

PMID:
25122732
[PubMed - as supplied by publisher]
2.

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR.

CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6.

PMID:
23801529
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Novel strategy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD.

Teicher MH, Lowen SB, Polcari A, Foley M, McGreenery CE.

J Child Adolesc Psychopharmacol. 2004 Summer;14(2):219-32.

PMID:
15319019
[PubMed - indexed for MEDLINE]
4.

Variability of response time as a predictor of methylphenidate treatment response in korean children with attention deficit hyperactivity disorder.

Lee SH, Song DH, Kim BN, Joung YS, Ha EH, Cheon KA, Shin YJ, Yoo HJ, Shin DW.

Yonsei Med J. 2009 Oct 31;50(5):650-5. doi: 10.3349/ymj.2009.50.5.650. Epub 2009 Oct 21.

PMID:
19881968
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD).

DeVito EE, Blackwell AD, Clark L, Kent L, Dezsery AM, Turner DC, Aitken MR, Sahakian BJ.

Psychopharmacology (Berl). 2009 Jan;202(1-3):531-9. doi: 10.1007/s00213-008-1337-y. Epub 2008 Sep 26.

PMID:
18818905
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Motivational incentives and methylphenidate enhance electrophysiological correlates of error monitoring in children with attention deficit/hyperactivity disorder.

Groom MJ, Liddle EB, Scerif G, Liddle PF, Batty MJ, Liotti M, Hollis CP.

J Child Psychol Psychiatry. 2013 Aug;54(8):836-45. doi: 10.1111/jcpp.12069. Epub 2013 May 13.

PMID:
23662815
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.

Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HL.

J Child Adolesc Psychopharmacol. 2011 Apr;21(2):121-31. doi: 10.1089/cap.2010.0047. Epub 2011 Apr 13.

PMID:
21488750
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
[PubMed - indexed for MEDLINE]
9.

Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.

Pearson DA, Santos CW, Casat CD, Lane DM, Jerger SW, Roache JD, Loveland KA, Lachar D, Faria LP, Payne CD, Cleveland LA.

J Am Acad Child Adolesc Psychiatry. 2004 Jun;43(6):677-85.

PMID:
15167084
[PubMed - indexed for MEDLINE]
10.

Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults.

Agay N, Yechiam E, Carmel Z, Levkovitz Y.

Psychopharmacology (Berl). 2010 Jul;210(4):511-9. doi: 10.1007/s00213-010-1853-4. Epub 2010 Apr 28.

PMID:
20424828
[PubMed - indexed for MEDLINE]
11.

Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder.

Solanto M, Newcorn J, Vail L, Gilbert S, Ivanov I, Lara R.

J Child Adolesc Psychopharmacol. 2009 Dec;19(6):663-71. doi: 10.1089/cap.2009.0033.

PMID:
20035584
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis.

Jain R, Babcock T, Burtea T, Dirks B, Adeyi B, Scheckner B, Lasser R.

Child Adolesc Psychiatry Ment Health. 2011 Nov 4;5(1):35. doi: 10.1186/1753-2000-5-35.

PMID:
22054243
[PubMed]
Free PMC Article
13.

Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD.

Hammerness P, Fried R, Petty C, Meller B, Biederman J.

Child Neuropsychol. 2014;20(3):319-27. doi: 10.1080/09297049.2013.790359. Epub 2013 May 2.

PMID:
23639146
[PubMed - indexed for MEDLINE]
14.

Long-term effects of stimulants on neurocognitive performance of Taiwanese children with attention-deficit/hyperactivity disorder.

Tsai CS, Huang YS, Wu CL, Hwang FM, Young KB, Tsai MH, Chu SM.

BMC Psychiatry. 2013 Dec 4;13:330. doi: 10.1186/1471-244X-13-330.

PMID:
24305033
[PubMed - indexed for MEDLINE]
Free Article
15.

Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.

Huang YS, Wang LJ, Chen CK.

BMC Psychiatry. 2012 Nov 9;12:194. doi: 10.1186/1471-244X-12-194.

PMID:
23140464
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD.

Paton K, Hammond P, Barry E, Fitzgerald M, McNicholas F, Kirley A, Robertson IH, Bellgrove MA, Gill M, Johnson KA.

Child Neuropsychol. 2014;20(3):303-18. doi: 10.1080/09297049.2013.790358. Epub 2013 May 2.

PMID:
23639119
[PubMed - indexed for MEDLINE]
17.

Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder.

Dittmann RW, Cardo E, Nagy P, Anderson CS, Adeyi B, Caballero B, Hodgkins P, Civil R, Coghill DR.

CNS Drugs. 2014 Jul 20. [Epub ahead of print]

PMID:
25038977
[PubMed - as supplied by publisher]
18.

Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral system methylphenidate.

Chou WJ, Chen SJ, Chen YS, Liang HY, Lin CC, Tang CS, Huang YS, Yeh CB, Chou MC, Lin DY, Hou PH, Wu YY, Liu HJ, Huang YF, Hwang KL, Chan CH, Pan CH, Chang HL, Huang CF, Hsu JW.

J Child Adolesc Psychopharmacol. 2012 Jun;22(3):215-25. doi: 10.1089/cap.2011.0006. Epub 2012 Apr 26.

PMID:
22537358
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.

Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C; 31001074-ATT2001 Study Investigators.

CNS Drugs. 2012 May 1;26(5):421-34. doi: 10.2165/11631990-000000000-00000.

PMID:
22519922
[PubMed - indexed for MEDLINE]
20.

Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.

Kim BN, Kim JW, Cummins TD, Bellgrove MA, Hawi Z, Hong SB, Yang YH, Kim HJ, Shin MS, Cho SC, Kim JH, Son JW, Shin YM, Chung US, Han DH.

J Clin Psychopharmacol. 2013 Jun;33(3):356-62. doi: 10.1097/JCP.0b013e31828f9fc3.

PMID:
23609393
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk